Search results for "main"

showing 10 items of 4384 documents

2015

Summary Background The ICON7 trial previously reported improved progression-free survival in women with ovarian cancer with the addition of bevacizumab to standard chemotherapy, with the greatest effect in patients at high risk of disease progression. We report the final overall survival results of the trial. Methods ICON7 was an international, phase 3, open-label, randomised trial undertaken at 263 centres in 11 countries across Europe, Canada, Australia and New Zealand. Eligible adult women with newly diagnosed ovarian cancer that was either high-risk early-stage disease (International Federation of Gynecology and Obstetrics [FIGO] stage I–IIa, grade 3 or clear cell histology) or more adv…

medicine.medical_specialtyBevacizumabbusiness.industrymedicine.diseaseChemotherapy regimenCarboplatinlaw.inventionSurgerychemistry.chemical_compoundOncologyRandomized controlled trialchemistryMaintenance therapylawInternal medicineClinical endpointMedicinebusinessOvarian cancerSurvival analysismedicine.drugThe Lancet Oncology
researchProduct

The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attenti…

2018

The prediction of acute and maintenance lithium treatment response carries major clinical and neurobiological implications, warranting systematic review. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) compliant review searched major electronic databases from inception until December 2017 for studies documenting a clinical diagnosis of bipolar disorder (BD) made according to the mainstream diagnostic manuals and confirmed by a structured interview. Eligible studies allowed a quantitative comparison of endpoint vs baseline mean values of a given biomarker, regardless of the mood phase of patients with BD, and the disorder was assessed for severity using validate…

medicine.medical_specialtyBiomedical ResearchBipolar DisorderLithium (medication)MaintenanceAcuteLithium03 medical and health sciences0302 clinical medicinePredictive Value of TestsmedicineHumansProspective StudiesBipolar disorderIntensive care medicineBiological PsychiatryRetrospective Studiesbusiness.industryResponseBiomarkerPublication biasBipolar disorder (BD)medicine.disease030227 psychiatryPsychiatry and Mental healthIdentification (information)Treatment OutcomeMoodSystematic reviewStructured interviewBiomarker (medicine)businessBiomarkers030217 neurology & neurosurgeryPredictormedicine.drugPsychiatry Research
researchProduct

In Reply: Cardiac Troponin T in End-Stage Renal Disease Patients Undergoing Chronic Maintenance Hemodialysis

1995

medicine.medical_specialtyCardiac troponinbusiness.industryInternal medicineBiochemistry (medical)Clinical BiochemistrymedicineCardiologyMaintenance hemodialysisIntensive care medicinebusinessEnd stage renal diseaseClinical Chemistry
researchProduct

ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission in…

2019

Treatment of vasculitides associated with anti-neutrophil cytoplasm antibodies (ANCA) (AAVs) has evolved dramatically in recent years, particularly since the demonstration of rituximab efficacy as remission induction and maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis. In 2013, the French Vasculitis Study Group (FVSG) published recommendations for its use by clinicians. Since then, new data have made it possible to better specify and codify prescription of rituximab to treat AAVs. Herein, the FVSG Recommendations Committee, an expert panel comprised of physicians with extensive experience in the treatment and management of vasculitides, presents its con…

medicine.medical_specialtyCardiologyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMaintenance Chemotherapy03 medical and health sciencesRemission induction0302 clinical medicineMaintenance therapymedicineHumans030212 general & internal medicineMedical prescriptionIntensive care medicineSocieties Medical030203 arthritis & rheumatologybusiness.industryRemission InductionGranulomatosis with PolyangiitisGeneral Medicinemedicine.diseaseBiological TherapyPractice Guidelines as TopicRituximabFranceGranulomatosis with polyangiitisbusinessMicroscopic polyangiitisVasculitisMepolizumabImmunosuppressive Agentsmedicine.drugLa Presse Médicale
researchProduct

Teaching Technology Usage in the ENT Medical Subdomain via a Flipped Classroom Approach

2018

The flipped classroom approach is supporting a continuous interaction of students and instructors via online communication and strengthens the ability to solve problems by self-organization. This is especially important in medical domains, like the one of ENT-Head/Neck (ENT: Ear-Nose-Throat) surgeries and treatment. Surgical corrections of the nasal airways, like FESS (Functional Endoscopy Sinus Surgery) or in the field of plastic surgery, are the second frequent surgical interventions in otorhinolaryngology. They have to be prepared very carefully and airflow simulation with Computational Fluid Dynamics (CFD) is gaining importance for diagnostics here. New in silico procedures, like imagin…

medicine.medical_specialtyCfd simulationComputer scienceLearning environmenteducationFlipped classroomField (computer science)Domain (software engineering)Visualization03 medical and health sciences0302 clinical medicineClinical pathwayOtorhinolaryngologyotorhinolaryngologic diseasesmedicineMedical physics030223 otorhinolaryngology030217 neurology & neurosurgeryInternational Journal of Advanced Corporate Learning (iJAC)
researchProduct

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

2020

Abstract Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the use of caplacizumab for a minimum of 30 days after stopping daily PEX. This study was a retrospective, observational analysis of the use of caplacizumab in 60 patients from 29 medical centers in Germany. Immunosuppressive treatment led to a rapid normalization of ADAMTS13 activities (calculated median, 21 days). In 35 of 60 patients, ADAMTS13 activities started to normalize before day 30 after PEX; in 11 of 60 patients, the treatment was…

medicine.medical_specialtyClinical Trials and Observationsmedicine.medical_treatmentMedizinADAMTS13 Protein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineVon Willebrand factorFibrinolytic AgentsInternal medicinehemic and lymphatic diseasesvon Willebrand FactormedicineHumansIn patientRetrospective StudiesAcquired Thrombotic Thrombocytopenic PurpurabiologyPurpura Thrombotic Thrombocytopenicbusiness.industryImmunosuppressionRetrospective cohort studyHematologySingle-Domain AntibodiesADAMTS13Cardiovascular and Metabolic Diseases030220 oncology & carcinogenesisbiology.proteinBiomarker (medicine)Caplacizumabbusiness
researchProduct

Impact of COVID-19 on hand surgery in Italy: A comparison between the Northern and the Southern regions

2021

The aims of this study were to evaluate the impact of the COVID-19 pandemic on emergency and elective hand surgery in four Italian regions that had either a high (Lombardy and Piemonte) or a low (Sicilia and Puglia) COVID-19 case load to discuss problems and to elaborate strategies to improve treatment pathways. A panel of hand surgeons from these different regions compared and discussed data from the centers they work in. The COVID-19 pandemic had an enormous impact on both elective and emergency surgery in Italy, not only in highly affected regions but also – and paradoxically even at a higher extent – in regions with a low COVID-19 case load. A durable and flexible redesign of hand surge…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentPersonnel Staffing and SchedulingHand surgery030230 surgeryHealth Services Accessibility03 medical and health sciences0302 clinical medicineCOVID-19 TestingEmergency surgeryChirurgie de la mainSurveys and QuestionnairesPandemicChirurgie élective de la mainmedicineHumansOperations managementOrthopedic ProceduresOrthopedics and Sports MedicineTelematicsHuman resourcesPandemicsPhysical Therapy ModalitiesPostoperative Care030222 orthopedicsRehabilitationbusiness.industryEmergency hand surgeryRehabilitationChirurgie d'urgence de la mainCOVID-19Hand surgeryHandTelemedicineGeographyWork (electrical)ItalyElective Surgical ProceduresCOVID-19 Hand surgery Elective hand surgery Emergency hand surgeryElective hand surgeryOriginal ArticleSurgerybusinessHand Surgery and Rehabilitation
researchProduct

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

2021

Abstract The efficacy and safety of caplacizumab in individuals with acquired thrombotic thrombocytopenic purpura (aTTP) have been established in the phase 2 TITAN and phase 3 HERCULES trials. Integrated analysis of data from both trials was conducted to increase statistical power for assessing treatment differences in efficacy and safety outcomes. Caplacizumab was associated with a significant reduction in the number of deaths (0 vs 4; P < .05) and a significantly lower incidence of refractory TTP (0 vs 8; P < .05) vs placebo during the treatment period. Consistent with the individual trials, treatment with caplacizumab resulted in a faster time to platelet count response (ha…

medicine.medical_specialtyExacerbationThrombotic thrombocytopenic purpura030204 cardiovascular system & hematologyPlaceboGastroenterology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRefractoryInternal medicinemedicineHumans610 Medicine & healthAcquired Thrombotic Thrombocytopenic PurpuraPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryHazard ratioHematologySingle-Domain Antibodiesmedicine.diseaseStimulus ReportTolerability030220 oncology & carcinogenesisCaplacizumabbusinessBlood Advances
researchProduct

Nutritional medicine as mainstream in psychiatry

2015

International audience; Psychiatry is at an important juncture, with the current pharmacologically focused model having achieved modest benefits in addressing the burden of poor mental health worldwide. Although the determinants of mental health are complex, the emerging and compelling evidence for nutrition as a crucial factor in the high prevalence and incidence of mental disorders suggests that diet is as important to psychiatry as it is to cardiology, endocrinology, and gastroenterology. Evidence is steadily growing for the relation between dietary quality (and potential nutritional deficiencies) and mental health, and for the select use of nutrient-based supplements to address deficien…

medicine.medical_specialtyHigh prevalencebusiness.industryMental DisordersAlternative medicineMEDLINEContext (language use)medicine.diseaseMental healthDiet3. Good healthPsychiatry and Mental healthMalnutrition[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthHumansMedicineMainstreamNutritional Physiological PhenomenaNutritional Physiological Phenomena[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]businessPsychiatryBiological PsychiatryRandomized Controlled Trials as Topic
researchProduct

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.

2006

New diagnostic criteria for polycystic ovary syndrome (PCOS) suggested three main phenotypes: classic (hyperandrogenism and anovulation), ovulatory, and normoandrogenic. However, it is unclear whether the normoandrogenic phenotype actually represents PCOS. Overall, 6% to 8% of reproductive-aged women suffer from PCOS, making this disorder one of the most common endocrine abnormalities.

medicine.medical_specialtyHirsutismendocrine system diseasesPolycystic ovary syndrome anovulation hyperandrogenismThree main phenotypesBiologyAnovulationDiagnosis DifferentialEpidemiologymedicinePrevalenceEndocrine systemHumansCystGynecologyHyperandrogenismnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseasePolycystic ovaryPhenotypefemale genital diseases and pregnancy complicationsPhenotypeReproductive MedicineFemaleHyperandrogenismAnovulationPolycystic Ovary SyndromeFertility and sterility
researchProduct